Corrigendum to "Nitrogen-containing heterocyclic drug products approved by the FDA in 2023: Synthesis and biological activity" [Eur. J. Med. Chem. 279 (2024) 116838]

Affiliations

• ¹ Department of Medicinal Chemistry, School of Pharmacy, Hengyang Medical School, University of South China, China.
• ² Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
• ³ School of Chemistry and Chemical Engineering, University of South China, Hengyang, Hunan, 421001, China. Electronic address: weiminhe@usc.edu.cn.
• ⁴ Hunan Province Key Laboratory for Antibody-based Drug and Intelligent Delivery System, School of Pharmaceutical Sciences, Hunan University of Medicine, China. Electronic address: tangss_submit@163.com.
• ⁵ Department of Medicinal Chemistry, School of Pharmacy, Hengyang Medical School, University of South China, China. Electronic address: pengmarina@126.com.